STRM

Streamline Health Solutions, Inc. (STRM) ESG Analysis Analysis (2026)

Invetso Score: 6.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 6.4 (Moderate)

STRM's R&D intensity is high at 25.9% of revenue, which can support lower-carbon product innovation versus peers, but the metric alone does not confirm environmental outcomes.

The company’s capital allocation appears more innovation-heavy than emissions-intensive, yet the absence of disclosed emissions, energy, or waste metrics limits evidence of peer-leading environmental management.

Compared with peers that report science-based targets and operational footprint data, STRM’s environmental positioning is harder to verify, which weakens transparency despite potentially favorable product-level effects.

No post-August 2025 filing evidence was provided on climate governance or environmental targets, so the assessment relies on limited disclosed inputs and remains moderate versus better-disclosed peers.

Social

Score:

STRM’s stock-based compensation equals 11.0% of revenue, which can align employee incentives with long-term value creation, but it may also indicate heavier dilution than peers.

High R&D spending at 25.9% of revenue suggests a knowledge-intensive workforce, which can support talent retention and skill development relative to more labor-light peers.

The available metrics do not disclose workforce turnover, safety, diversity, or labor relations, so STRM cannot be assessed as strongly as peers with fuller social reporting.

Relative to peers with clearer human-capital disclosures, STRM’s social profile is mixed because incentive alignment is visible while broader employee metrics remain undisclosed.

Governance

Score:

Debt-to-equity of 1.07 indicates moderate leverage, which can constrain governance flexibility versus lower-levered peers if capital discipline weakens.

Net debt to EBITDA of -3.32 suggests a net cash position, which supports balance-sheet resilience and reduces creditor pressure relative to leveraged peers.

Stock-based compensation at 11.0% of revenue is material, so governance quality depends on whether dilution is tightly controlled compared with peers.

Without board composition, audit, or shareholder-rights disclosures, STRM’s governance assessment remains moderate because financial discipline is visible but oversight quality is not.

Overall Score

Score:

STRM screens as a moderate ESG performer versus peers because innovation intensity and balance-sheet resilience are visible, but disclosure depth is limited across all three pillars.

Score Driver: Limited ESG Disclosure Visibility Relative To Peers

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Streamline Health Solutions, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →